Table 1.
Cell type | Origin | Isolation/expansion | Colony formation and type | In vitro properties
|
In vivo properties
|
Surface phenotype | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AcLDL uptake | Lectin binding | eNOS vWf | Tube formation | In vivo homing ischemic sites | Vasculogenesis | Paracrine effect | ||||||
Historical EPCs [Ref. 28] | Blood | PB-MNCs enriched for CD34→plating→expansion of adherent cells | At 7 days, clusters of round cells surrounded by spindle-shaped cells expressing EC markers | + | Not tested | + | + | + | + | Not tested | CD34+ VEGFR2+ CD45+/− CD31+ |
|
Early outgrowth | CFU-Hill | Blood | Preplating of PB-MNCs→selective replating and expansion of non-adherent cells | At 5 days, colonies characterized by elongated sprouting cells radiating from a central cluster and expressing EC markers | + | + | +/− | + | + | − | + | CD34+/− CD133+ VEGFR2+ CD45+/− CD14+/− CD115+ CD31+ |
CACs | Blood | Plating of PB-MNCs→at 4 days, removal of non-adherent cells→characterization of adherent cells | At 4 days, adherent cells express EC markers but do not form colonies | + | + | +/− | + | + | − | + | CD34+/− CD133+ VEGFR2+ CD45+/− CD14+/− CD115+ CD31+ |
|
Late outgrowth | Blood Umbilical cord Vessel wall Bone marrow |
Plating of PB-MNCs→removal of non-adherent cells→at 7–21 days, colony formation | At 7–21 days, colonies of highly proliferative ECs | + | + | + | + | + | + | +/− | CD34+ CD133− VEGFR2+ CD45− CD14− CD115− CD31+ |
|
VSCs | Heart | Enzymatic digestion of cardiac tissue→sorting for c-kit and KDR→expansion in vitro | At 2–3 weeks, multicellular clones derive from single cells | Not tested | Not tested | + (after differentiation) | Not tested | + | + | − | c-kit+ CD34− CD133− VEGFR2+ CD45− CD14− CD115− CD31− |
EPCs endothelial progenitor cells, CFU colony-forming unit, CACs circulating angiogenic cells, ECFCs endothelial colony-forming cells, PB-MNCs peripheral blood mononuclear cells, EC endothelial cell, AcLDL acetylated low-density lipoprotein, eNOS endothelial nitric oxide synthase, vWf von Willebrand factor, VSCs vascular stem cells